Abstract
Familial hypercholesterolaemia (FH) is an under-recognised cause of coronary artery disease, despite the proven reductions in risk with early detection and treatment [ [1] Versmissen J. et al. BMJ. 2008; 337: a2423 Crossref PubMed Scopus (548) Google Scholar ]. Studies have estimated that the prevalence of FH in patients with coronary disease range from 1–19% [ [2] Pang J. et al. J Clin Lipidol. 2015; 9: 703-708 Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar ].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
